- Home
- MXCT vs GBLI Comparison
MXCT vs GBLI Comparison
Compare MXCT & GBLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXCT
- GBLI
- Stock Information
- Founded
- MXCT 1999
- GBLI 2016
- Country
- MXCT United States
- GBLI United States
- Employees
- MXCT N/A
- GBLI N/A
- Industry
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GBLI Property-Casualty Insurers
- Sector
- MXCT Health Care
- GBLI Finance
- Exchange
- MXCT Nasdaq
- GBLI Nasdaq
- Market Cap
- MXCT 534.8M
- GBLI 476.1M
- IPO Year
- MXCT 2021
- GBLI 2003
- Fundamental
- Price
- MXCT $5.06
- GBLI $35.76
- Analyst Decision
- MXCT Strong Buy
- GBLI
- Analyst Count
- MXCT 2
- GBLI 0
- Target Price
- MXCT $9.50
- GBLI N/A
- AVG Volume (30 Days)
- MXCT 565.6K
- GBLI 4.7K
- Earning Date
- MXCT 03-11-2025
- GBLI 03-12-2025
- Dividend Yield
- MXCT N/A
- GBLI 3.95%
- EPS Growth
- MXCT N/A
- GBLI 90.04
- EPS
- MXCT N/A
- GBLI 2.92
- Revenue
- MXCT $45,599,000.00
- GBLI $442,500,000.00
- Revenue This Year
- MXCT N/A
- GBLI N/A
- Revenue Next Year
- MXCT $21.13
- GBLI $8.39
- P/E Ratio
- MXCT N/A
- GBLI $12.14
- Revenue Growth
- MXCT 19.85
- GBLI N/A
- 52 Week Low
- MXCT $3.17
- GBLI $27.47
- 52 Week High
- MXCT $5.29
- GBLI $37.00
- Technical
- Relative Strength Index (RSI)
- MXCT 66.94
- GBLI 48.31
- Support Level
- MXCT $4.64
- GBLI $33.12
- Resistance Level
- MXCT $5.20
- GBLI $36.51
- Average True Range (ATR)
- MXCT 0.30
- GBLI 0.84
- MACD
- MXCT 0.05
- GBLI -0.14
- Stochastic Oscillator
- MXCT 88.19
- GBLI 55.95
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
About GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance worldwide. The company's three primary segments are Commercial Specialty, Reinsurance operations, and Exited Lines. The majority of its revenue is from the Commercial Specialty segment. Geographically, the majority is from California.